Literature DB >> 2573734

Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma.

I U Ali1, R Lidereau, R Callahan.   

Abstract

The loss of heterozygosity of genes on the short arm of chromosome 3 (3p) in human breast carcinomas occurs in a region involved in other malignancies, including renal cell carcinoma, lung cancers, and von Hippel-Lindau disease. This finding suggests the presence of a gene(s) that plays a crucial role in multiple cancers. In our study of 84 informative (heterozygous) primary breast tumors, 30% showed losses of heterozygosity on chromosome 3. The shortest region of homozygosity in primary human breast tumor is located between the DNF15S2 and RAF1 loci in the 3p21-p25 region on the short arm of chromosome 3. This region includes at least two members of the c-erbA steroid/thyroid hormone receptor family (c-erbA beta and c-erbA2) that may be of special relevance to breast cancer. Furthermore, tumors with a loss of heterozygosity of genes on chromosome 3 were previously reported to have frequent allelic deletions on chromosome 11p and amplification of the c-myc proto-oncogene. These results highlight the occurrence of multiple genetic alterations in breast tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573734     DOI: 10.1093/jnci/81.23.1815

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  19 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Cytogenetic studies on a patient with prepubertal breast cancer: a case report.

Authors:  B R Balsara; T Varughese; A V Bhat; R S Rao; A N Bhisey
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Chromosomal abnormalities in human breast cancer.

Authors:  W M Mars; G F Saunders
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

Review 4.  Genetic analysis of breast cancer progression.

Authors:  S H Dairkee; H S Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

Review 5.  Familial breast cancer and genes involved in breast carcinogenesis.

Authors:  A Lindblom
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  Positional cloning of the hereditary renal carcinoma 3;8 chromosome translocation breakpoint.

Authors:  F L Boldog; R M Gemmill; C M Wilke; T W Glover; A S Nilsson; S C Chandrasekharappa; R S Brown; F P Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

7.  Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors.

Authors:  D Chatterjee; C J Liu; D Northey; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.

Authors:  G R Merlo; T Venesio; A Bernardi; L Canale; P Gaglia; D Lauro; A P Cappa; R Callahan; D S Liscia
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Definition of a tumor suppressor locus within human chromosome 3p21-p22.

Authors:  A M Killary; M E Wolf; T A Giambernardi; S L Naylor
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

10.  Loss of heterozygosity of the L-myc oncogene in human breast tumors.

Authors:  I Bieche; M H Champeme; G Merlo; C J Larsen; R Callahan; R Lidereau
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.